dexamethasone
Showing 51 - 75 of 1,649
Post Operative Nausea and Vomiting Trial in Cairo (Mirtazapine 30 MG, Dexamethasone)
Recruiting
- Post Operative Nausea and Vomiting
- Mirtazapine 30 MG
- Dexamethasone
-
Cairo, Abassia, EgyptAin Shams University
Aug 4, 2022
Postoperative Pain, Lower Limb Injury Trial in Lausanne (Dexamethasone, NaCl 0.0308 MEQ/ML Injectable Solution)
Completed
- Postoperative Pain
- Lower Limb Injury
- Dexamethasone
- NaCl 0.0308 MEQ/ML Injectable Solution
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois and University of Lausa
Jul 19, 2022
Multiple Myeloma, Relapse, Refractory Trial in Chapel Hill, Winston-Salem, Columbus (Isatuximab, Pomalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- +4 more
- Isatuximab
- +2 more
-
Chapel Hill, North Carolina
- +2 more
Jun 9, 2023
Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), Virus Diseases Trial in Cayenne (Tocilizumab, Dexamethasone)
Completed
- Coronavirus Infection
- +7 more
- Tocilizumab
- Dexamethasone
-
Cayenne, French GuianaCH Andrée Rosemon
Jun 7, 2022
Allogenic Granulocyte Donation Trial run by the National Institutes of Health Clinical Center (CC) (Filgrastim, Dexamethasone)
Recruiting
- Allogeneic Granulocyte Donation
- Filgrastim
- Dexamethasone
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)
Not yet recruiting
- Relapsed Refractory Multiple Myeloma
- REGN5458
- +3 more
- (no location specified)
Feb 6, 2023
Cutaneous T-Cell Lymphoma, Mature T-cell Malignancies, Peripheral T-Cell Lymphoma Trial run by the NCI (Romidepsin,
Recruiting
- Cutaneous T-Cell Lymphoma
- +3 more
- Romidepsin
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)
Recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG
- Dexamethasone
-
Beijing, China
- +9 more
Jul 11, 2023
Glioblastoma, Malignant Glioma Trial in Duarte (Azeliragon, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Glioblastoma
- Malignant Glioma
- Azeliragon
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 6, 2023
Shoulder Pain Trial in New York (Exparel 133 MG Per 10 ML Injection, Dexamethasone)
Completed
- Shoulder Pain
- Exparel 133 MG Per 10 ML Injection
- Dexamethasone
-
New York, New YorkHospital for Special Surgery
Jul 7, 2022
Ocular Inflammation, Ocular Prostheses Trial in Rennes (Hydrocortisone, Dexamethasone, Povidone)
Not yet recruiting
- Ocular Inflammation
- Ocular Prostheses
- Hydrocortisone
- +2 more
-
Rennes, FranceCentre Hospitalier Universitaire de Rennes _ Pontchaillou
Dec 20, 2022
Voice Change, Hypocalcemia Trial (Dexamethasone, Normal saline)
Not yet recruiting
- Voice Change
- Hypocalcemia
- Dexamethasone
- Normal saline
- (no location specified)
Feb 8, 2023
Coronary Artery Disease, Inflammatory Response Trial in Jakarta (Dexamethasone, Normal saline)
Completed
- Coronary Artery Disease
- Inflammatory Response
- Dexamethasone
- Normal saline
-
Jakarta, DKI Jakarta, IndonesiaNational Cardiovascular Center Harapan Kita
Aug 2, 2022
Colorectal Disorders, Regional Anesthesia Morbidity, Analgesia Trial (Dexamethasone)
Not yet recruiting
- Colorectal Disorders
- +7 more
- Dexamethasone
- (no location specified)
Jun 24, 2022
Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,
Recruiting
- Multiple Myeloma
- Monoclonal Gammopathy of Renal Significance
- Cyclophosphamide
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Oct 16, 2023
Arthroplasty, Replacement, Shoulder Trial in Lugano (dexamethasone)
Recruiting
- Arthroplasty, Replacement, Shoulder
- dexamethasone
-
Lugano, SwitzerlandChristian Candrian
Jul 13, 2022
Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)
Active, not recruiting
- Multiple Myeloma
- daratumumab
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Dec 28, 2022
ACL, Postoperative Pain Trial in Philadelphia (Exparel 30 mL, 0.5% bupivacaine, Dexamethasone)
Enrolling by invitation
- ACL
- Postoperative Pain
- Exparel 30 mL
- +3 more
-
Philadelphia, PennsylvaniaRothman Orthopaedic Institute
Aug 22, 2023
Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)
Active, not recruiting
- Primary Systemic Amyloidosis
- Light Chain Deposition Disease
- bortezomib
- +6 more
-
Denver, Colorado
- +6 more
Aug 24, 2022
Immune Thrombocytopenia Trial (Zanubrutinib, Dexamethasone)
Not yet recruiting
- Immune Thrombocytopenia
- Zanubrutinib
- Dexamethasone
- (no location specified)
May 6, 2022
Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,
Active, not recruiting
- Light Chain Deposition Disease
- Primary Systemic Amyloidosis
- pomalidomide
- +3 more
-
Denver, Colorado
- +4 more
Jan 20, 2023
Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)
Recruiting
- Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023